These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 12911332

  • 1. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P, Sun NK, Chao CC.
    Biochem J; 2003 Nov 15; 376(Pt 1):253-60. PubMed ID: 12911332
    [Abstract] [Full Text] [Related]

  • 2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 3. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 4. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 01; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 5. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar 01; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 6. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF, Xiao C, Li H, Yang SJ.
    Clin Exp Pharmacol Physiol; 2007 Dec 01; 34(12):1245-51. PubMed ID: 17973862
    [Abstract] [Full Text] [Related]

  • 7. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V, Mitsiades N, Romero ME, Tsokos M.
    Cancer Res; 2001 Jun 15; 61(12):4864-72. PubMed ID: 11406564
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G.
    Arthritis Rheum; 2004 Feb 15; 50(2):498-506. PubMed ID: 14872492
    [Abstract] [Full Text] [Related]

  • 9. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H, Yonehara S.
    Immunol Lett; 2007 Mar 15; 109(1):36-46. PubMed ID: 17275920
    [Abstract] [Full Text] [Related]

  • 10. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Mar 15; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
    Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ.
    Eur J Immunol; 2000 Jan 15; 30(1):155-63. PubMed ID: 10602037
    [Abstract] [Full Text] [Related]

  • 14. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 15; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of death receptor signals by cellular FLIP.
    Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J.
    Nature; 1997 Jul 10; 388(6638):190-5. PubMed ID: 9217161
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
    Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV.
    J Immunol; 1999 May 01; 162(9):5205-11. PubMed ID: 10227994
    [Abstract] [Full Text] [Related]

  • 17. Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells.
    Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, Brown D, Mor G.
    Oncogene; 2003 May 01; 22(17):2611-20. PubMed ID: 12730675
    [Abstract] [Full Text] [Related]

  • 18. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes.
    Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A, Coutant A, Baffet G, Peter ME, Fardel O, Guguen-Guillouzo C.
    Carcinogenesis; 2005 Dec 01; 26(12):2086-94. PubMed ID: 16033771
    [Abstract] [Full Text] [Related]

  • 19. Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.
    Sun CL, Chao CC.
    Mol Pharmacol; 2005 Apr 01; 67(4):1307-14. PubMed ID: 15644494
    [Abstract] [Full Text] [Related]

  • 20. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL.
    J Cell Biochem; 2007 Jan 01; 100(1):16-28. PubMed ID: 16888780
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.